TY - JOUR T1 - Safety of caplacizumab in patients without documented severe adamts13 deficiency during the hercules study JO - Hematology, Transfusion and Cell Therapy T2 - AU - Besisik,S. AU - Rubia,J. De La AU - Peyvandi,F. AU - Scully,M. AU - Cataland,S. AU - Coppo,P. AU - Hovinga,J. A. Kremer AU - Knoebl,P. AU - Metjian,A. AU - Pavenski,K. AU - De Winter,H. AU - Sousa,R. De Passos AU - Callewaert,F. SN - 25311379 M3 - 10.1016/j.htct.2020.09.111 DO - 10.1016/j.htct.2020.09.111 UR - http://www.htct.com.br/en-safety-caplacizumab-in-patients-without-articulo-S253113792030242X ER -